Dassault Systemes Unveils ENOVIA Life Sciences Accelerator for Engineering Design.Developed on New V6 Platform, Accelerator Automates Product Design and Regulatory Deliverables for Medical Device Companies LOWELL, Mass. -- Dassault Syst[c]mes (DS) (Paris:DSY DSY Drum Storage Yard ) (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :DASTY), a world leader in 3D and Product Lifecycle Product lifecycle or product life cycle is the course of a product's sales and profits over time. The five stages of each product lifecycle are product development, introduction, growth, maturity and decline. Management (PLM (Product Life cycle Management) A comprehensive information system that coordinates all aspects of a product from initial concept to its eventual retirement. Sometimes called the "digital backbone" of a product, it includes the requirements phase, analysis and design ) solutions, today announced the availability of a new PLM solution developed specifically for the Life Sciences industry. The ENOVIA Life Sciences Accelerator for Engineering Design[TM], developed on the recently announced V6 platform, delivers enterprise design data control for medical device companies. In order to succeed in an increasingly competitive and highly regulated market A regulated market is the provision of goods or services that is regulated by a government appointed body. The regulation may cover the terms and conditions of supplying the goods and services and in particular the price allowed to be charged. , medical device companies need to focus on business design processes and managing intellectual assets effectively across the medical-device value chain. The ENOVIA Life Sciences Accelerator for Engineering Design provides design control capabilities to manage all elements of the Device Master Record (DMR (Digital Media Receiver) See digital media hub. ) with a single, integrated system. This includes product data such as mechanical and electrical bills of materials (BOMs), CAD models, configurations and related documentation such as drawings, specifications, procedures and quality standards. It also aggregates all information related to products and parts from other business processes and functions within a company's product lifecycle management system. "No other industry is as regulated as Life Sciences and regulatory compliance is often a critical success factor in launching new products. It's therefore vital that we are able to stay compliant across a number of regulatory agencies, including the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. ," said James Rolfe, IT program manager, MEDRAD. "ENOVIA's solutions enable us to bring products to market quickly and more reliably by allowing us to focus on the creative aspects of the design, rather than the administrative details." Announced on May 29th, 2008, the Dassault Syst[c]mes V6 platform provides an open, online collaborative environment, on a single IP management platform, for all product lifecycle activities. The V6 architecture also includes ready-to-use business processes, such as program, compliance and quality issues management, which support industry-specific PLM best practices and capabilities. This approach ensures the Life Sciences Accelerator for Engineering Design addresses a customer's need to manage and monitor entire product lifecycles in an ad hoc For this purpose. Meaning "to this" in Latin, it refers to dealing with special situations as they occur rather than functions that are repeated on a regular basis. See ad hoc query and ad hoc mode. manner, while remaining on-time and on-budget. In addition V6's IP Lifecycle Management of all product-related information, such as bills of material (BOMs) is a crucial element to ensuring the long-term compliance and success of many life science companies. "Essentially, this solution is designed to be 'a single source of the truth' for medical device product structure and data," said Mickey Garcia, director of life sciences industry strategy, ENOVIA, Dassault Syst[c]mes. "As changes are made to the product design information, the Accelerator automatically updates this data throughout all the related systems." About Dassault Syst[c]mes: As a world leader in 3D and Product Lifecycle Management (PLM) solutions, Dassault Syst[c]mes (Nasdaq: DASTY; Euronext Paris: #13065, DSY.PA) brings value to more than 100,000 customers in 80 countries. A pioneer in the 3D software market since 1981, Dassault Syst[c]mes develops and markets PLM application software and services that support industrial processes and provide a 3D vision of the entire lifecycle of products from conception to maintenance to recycling. The Dassault Syst[c]mes portfolio consists of CATIA A family of 2D and 3D CAD programs from IBM. CATIA was one of the first CAD programs to provide 3D solid modeling. The program was developed by Dassault Systems, a French aerospace company. for designing the virtual product - SolidWorks for 3D mechanical design - DELMIA DELMIA Digital Enterprise Lean Manufacturing Interactive Application for virtual production - SIMULIA for virtual testing - ENOVIA for global collaborative lifecycle management, and 3DVIA DVIA Dvi Analog for online 3D lifelike experiences. Dassault Syst[c]mes is listed on the Nasdaq (DASTY) and Eurolist (#13065, DSY.PA) stock exchanges. For more information, visit http://www.3ds.com. CATIA, DELMIA, ENOVIA, SIMULIA, SolidWorks and 3D VIA are registered trademarks of Dassault Syst[c]mes or its subsidiaries in the US and/or other countries. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion